ConductScience.org, home

Paper6519151

Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone.

Ho PC and 3 others. Eur J Clin Pharmacol, 1984. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone. Papers, record 6519151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6519151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2019-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ho PCP C
2Bourne DWD W
3Triggs EJE J
4Heazlewood VV

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CanrenoneMajor topic
PregnadienesMajor topic
SpironolactoneMajor topic
Administration, Oral
Adult
Biotransformation
Chromatography, High Pressure Liquid
Female
Humans
Hydrolysis
Kinetics
Male
Spectrometry, Fluorescence

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1894500Simultaneous automated determination of spironolactone metabolites in serum.J Pharm Sci1977https://conductscience.org/library/papers/894500PubMed
26886998Estimating the accumulation of drugs.J Pharm Sci1983https://conductscience.org/library/papers/6886998PubMed
34712657Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4712657PubMed
4856602Disposition kinetics of spironolactone in hepatic failure after single doses and prolonged treatment.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/856602PubMed
57329203Conversion of spironolactone to an active metabolite in target tissues: formation of 7 alpha-thiospironolactone by microsomal preparations from guinea pig liver, adrenals, kidneys, and testes.Life Sci1981https://conductscience.org/library/papers/7329203PubMed
638071Re-evaluation of the antimineralocorticoid effect of the spironolactone metabolite, canrenone, from plasma concentrations determined by a new high-pressure liquid-chromatographic method.Drug Metab Dispos1979https://conductscience.org/library/papers/38071PubMed
71261155Spironolactone. III. Canrenone--maximum and minimum steady-state plasma levels.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1261155PubMed
81012347Pharmacokinetics of spironolactone in man.Naunyn Schmiedebergs Arch Pharmacol1976https://conductscience.org/library/papers/1012347PubMed
9858213Spironolactone and canrenoate-K: relative potency at steady state.Clin Pharmacol Ther1977https://conductscience.org/library/papers/858213PubMed
105044814Fluorometric microassay for spironolactone and its metabolites in biological fluids.J Pharm Sci1972https://conductscience.org/library/papers/5044814PubMed
11973942Antagonism of fludrocortisone by spironolactone and canrenone.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973942PubMed
126831747Pharmacokinetics of spironolactone after a single dose: evaluation of the true canrenone serum concentrations during 24 hours.Clin Exp Hypertens A1983https://conductscience.org/library/papers/6831747PubMed
131261154Spironolactone. II. Bioavailability.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1261154PubMed
14780038Spironolactone and potassium canrenoate in normal man.Clin Pharmacol Ther1976https://conductscience.org/library/papers/780038PubMed
151261153Spironolactone. I. Disposition and metabolism.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1261153PubMed
16872489Enhancement by food of canrenone bioavailability from spironolactone.Clin Pharmacol Ther1977https://conductscience.org/library/papers/872489PubMed
1722216502Canrenone--the principal active metabolite of spironolactone?Br J Clin Pharmacol1976https://conductscience.org/library/papers/22216502PubMed
18363379Spironolactone: disposition, metabolism, pharmacodynamics, and bioavailability.Drug Metab Rev1978https://conductscience.org/library/papers/363379PubMed
194853286Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4853286PubMed
207130430Effect of micronization on the bioavailability and pharmacologic activity of spironolactone.J Clin Pharmacol1982https://conductscience.org/library/papers/7130430PubMed

See all 22 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42196253Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of Hyperkalemia.Int J Mol Sci2026https://conductscience.org/library/papers/42196253PubMed
23836977Aldosterone receptor antagonists: current perspectives and therapies.Vasc Health Risk Manag2013https://conductscience.org/library/papers/23836977PubMed
6519150Comparison of plasma levels of canrenone and metabolites after base hydrolysis in young and elderly subjects following single and multiple doses of spironolactone.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6519150PubMed
2292169The effect of respiratory disorders on clinical pharmacokinetic variables.Clin Pharmacokinet1990https://conductscience.org/library/papers/2292169PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6519151

GET https://conductscience.org/api/papers/v1/6519151/references?page=2